Coronary artery calcium scoring (CCS) is a valuable non-invasive method for assessing atherosclerosis and performing risk stratification in patients with suspected coronary artery disease (CAD). Monocyte subsets play distinct roles in chronic inflammation and cardiovascular disease, potentially serving as biomarkers for CCS risk assessment. The aim of this study was to analyze the distribution of monocyte subsets in patients with suspected CAD and determine the association of monocyte subsets with CCS.
A cohort of 182 individuals with suspected CAD was enrolled. Participants were stratified into three groups based on their CCS scores: very low-risk (CCS = 0), low-risk (CCS = 1−99), and moderate–high risk (CCS ≥ 100). Monocyte subsets were categorized according to CD14 and CD16 expression levels into classical, intermediate (intMo), and non-classical monocytes. Absolute counts and frequency distribution of monocyte subsets (FDMS, percentage of CD45+/CD14+/CD16+ events) were analyzed across all participants.
Patients in the moderate–high risk CCS group had significantly higher absolute circulating monocyte counts than those in the other two groups (p < 0.05). Furthermore, the moderate–high risk CCS group had the highest absolute intMo count and FDMS (percentage of CD45+/CD14+/CD16+ events, p < 0.05). Both the absolute intMo count (Model 1: odds ratio [OR] = 1.024, 95% confidence interval [CI]: 1.009−1.040, p = 0.002) and FDMS (percentage of CD45+/CD14+/CD16+ events, Model 2: OR = 1.109, 95% CI = 1.039−1.183, p = 0.002) were identified as independent risk factors for moderate–high risk CCS.
These data suggest that intMo may be a useful biomarker for CCS risk stratification.
SilvermanMGBlahaMJKrumholzHM, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J2014; 35(33): 2232–2241.
2.
BudoffMJShawLJLiuST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol2007; 49(18): 1860–1870.
3.
HechtHSBlahaMJKazerooniEA, et al. CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the society of cardiovascular computed tomography (SCCT). J Cardiovasc Comput Tomogr2018; 12(3): 185–191.
4.
OhESNaMRogersCJ. The Association between monocyte subsets and cardiometabolic disorders/cardiovascular disease: a systematic review and meta-analysis. Front Cardiovasc Med2021; 8: 640124.
5.
JullaJBGirardDDiedisheimM, et al. Blood monocyte phenotype is a marker of cardiovascular risk in type 2 diabetes. Circ Res2024; 134(2): 189–202.
6.
ÇelikABezginTKaraaslanMB, et al. The relationship between coronary artery calcium score and monocyte to high-density lipoprotein cholesterol ratio in patients with stable angina pectoris. Turk Kardiyol Dern Ars2022; 50(8): 583–589.
7.
Ziegler-HeitbrockLAncutaPCroweS, et al. Nomenclature of monocytes and dendritic cells in blood. Blood2010; 116(16): e74–e80.
8.
WongKLTaiJJWongWC, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood2011; 118(5): e16–e31.
9.
MerinopoulosIBhalraamUHolmesT, et al. Circulating intermediate monocytes CD14++CD16+ are increased after elective percutaneous coronary intervention. PLoS One2023; 18(12): e0294746.
10.
MarkofskiMMFlynnMG. Elevated circulating CD16+ monocytes and TLR4+ monocytes in older adults with multiple cardiometabolic disease risk factors. Exp Gerontol. 2021; 154: 111530.
11.
ArnoldKABlairJEPaulJD, et al. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease. Exp Physiol2019; 104(9): 1343–1352.
12.
AskariNLippsCVossS, et al. Circulating monocyte subsets are associated with extent of myocardial injury but not with type of myocardial infarction. Front Cardiovasc Med2021; 8: 741890.
13.
AgatstonASJanowitzWRHildnerFJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol1990; 15(4): 827–832.
14.
McClellandRLChungHDetranoR, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation2006; 113(1): 30–37.
15.
Al RifaiMYaoJGuoX, et al. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Prog Cardiovasc Dis2022; 74: 19–27.
16.
DetranoRHsiaiTWangS, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol1996; 27(2): 285–290.
17.
CarrJJNelsonJCWongND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology2005; 234(1): 35–43.
18.
HechtHBlahaMJBermanDS, et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr2017; 11(2): 157–168.
19.
HechtHSCroninPBlahaMJ, et al. 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the society of cardiovascular computed tomography and society of thoracic radiology. J Cardiovasc Comput Tomogr2017; 11(1): 74–84.
20.
ShawLJGiambroneAEBlahaMJ, et al. Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study. Ann Intern Med2015; 163(1): 14–21.
21.
BudoffMJRaggiPBellerGA, et al. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the imaging council of the American college of cardiology. JACC Cardiovasc Imaging2016; 9(2): 176–192.
22.
BeigneuxYSablayrollesJLVarenneO, et al. Coronary artery calcium score improves the prediction of occult coronary artery stenosis in ischemic stroke patients. J Am Heart Assoc2016; 5(11): e003770.
23.
BlahaMJCainzos-AchiricaMGreenlandP, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation2016; 133(9): 849–858.
24.
MortensenMBGaurSFrimmerA, et al. Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients. JAMA Cardiol2022; 7(1): 36–44.
25.
PengAWMirboloukMOrimoloyeOA, et al. Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC ≥1000: results from the CAC consortium. JACC Cardiovasc Imaging2020; 13(1 Pt. 1): 83–93.
26.
YamamotoESugiyamaSHirataY, et al. Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease. Atherosclerosis2016; 255: 210–216.
27.
ZhangYLiSGuoYL, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med2016; 48(5): 305–312.
28.
ZeeshanMYousafSAhmedA, et al. Co-relation of monocyte count in high vs. low thrombus burden ST-Segment Elevated Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention. Cureus2022; 14(4): e24344.
29.
KomaravoluRKAraujoDJHedrickCC, et al. Transcriptional programs underlying human monocyte differentiation and diversity. J Leukoc Biol2025;117(7): qiaf058.
MartinetWSchrijversDMDe MeyerGR. Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Res Cardiol2012; 107(6): 297.
33.
ByonCHSunYChenJ, et al. Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler Thromb Vasc Biol2011; 31(6): 1387–1396.
34.
DonosoOPinoAMSeitzG, et al. Osteoporosis-associated alteration in the signalling status of BMP-2 in human MSCs under adipogenic conditions. J Cell Biochem2015; 116(7): 1267–1277.
35.
JinHSt. HilaireCHuangY, et al. Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC. Sci Signal2016; 9(458): ra121.
36.
TappLDShantsilaEWrigleyBJ, et al. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost2012; 10(7): 1231–1241.
37.
TsujiokaHImanishiTIkejimaH, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol2009; 54(2): 130–138.
ZhouXLiuXLJiWJ, et al. The kinetics of circulating monocyte subsets and monocyte-platelet aggregates in the acute phase of ST-elevation myocardial infarction: associations with 2 year cardiovascular events. Medicine (Baltimore)2016; 95(18): e3466.
40.
ZengSYanLFLuoYW, et al. Trajectories of circulating monocyte subsets after ST-elevation myocardial infarction during hospitalization: latent class growth modeling for high-risk patient identification. J Cardiovasc Transl Res2018; 11(1): 22–32.
41.
CappellariRD’AnnaMBonoraBM, et al. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes. Atherosclerosis2017; 266: 95–102.
42.
RogacevKSCremersBZawadaAM, et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol2012; 60(16): 1512–1520.
43.
ZeynalovaSBuckschKScholzM, et al. Monocyte subtype counts are associated with 10 year cardiovascular disease risk as determined by the Framingham risk score among subjects of the LIFE-Adult study. PLoS One2021; 16(3): e0247480.
44.
ChatterjeeNKomaravoluRKDurantCP, et al. Single cell high dimensional analysis of human peripheral blood mononuclear cells reveals unique intermediate monocyte subsets associated with sex differences in coronary artery disease. Int J Mol Sci2024; 25(5): 2894.
45.
DregoescMIȚiguABBekkeringS, et al. Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease. Int J Cardiol2024; 400: 131780.
46.
LoSCLeeWJChenCY, et al. Intermediate CD14(++)CD16(+) monocyte predicts severe coronary stenosis and extensive plaque involvement in asymptomatic individuals. Int J Cardiovasc Imaging2017; 33(8): 1223–1236.
47.
YoshidaNYamamotoHShinkeT, et al. Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study. Cardiovasc Diabetol2017; 16(1): 96.
48.
YamamotoHYoshidaNShinkeT, et al. Impact of CD14(++)CD16(+) monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients. Atherosclerosis2018; 269: 245–251.
49.
MeeuwsenJALde VriesJJvan DuijvenvoordeA, et al. Circulating CD14(+)CD16(-) classical monocytes do not associate with a vulnerable plaque phenotype, and do not predict secondary events in severe atherosclerotic patients. J Mol Cell Cardiol2019; 127: 260–269.
50.
BakerJVHullsiekKHSinghA, et al. Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort. Aids2014; 28(6): 831–840.
51.
LiCQuLMatzAJ, et al. AtheroSpectrum reveals novel macrophage foam cell gene signatures associated with atherosclerotic cardiovascular disease risk. Circulation2022; 145(3): 206–218.
